Roger S. Newton, Executive Chairman, CSO at Esperion Therapeutics, Inc. (ESPR), bought 343,397 shares at $14.00 ($593K) on 2013-07-01, disclosed to the SEC on 2013-07-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 301,051 | $0 | 0.0% |
| 2 | $14.00 | 42,346 | $593K | 100.0% |
| Total | $1.73 avg | 343,397 | $593K | 100% |
| Filing → |
| ESPR | SELL | 2018-10-18 | $1.7M | — | Filing → |
| ESPR | SELL | 2018-08-29 | $904K | — | Filing → |
| ESPR | SELL | 2018-08-22 | $365K | — | Filing → |